Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Privately-held company GAIA has had more than a front-row seat to observe the arrival of digital therapeutics and applications of AI in pharma over the past quarter century. 4 June 2024
The use of AI across all industries and sectors has been heralded as driving efficiency and accelerating innovation, with some experts even citing the technology as the biggest disruptor of our lifetime. 21 May 2024
At a cool $1 billion, the venture round secured by AI group Xaira ranks as the second-biggest raise in biotech history. In the drug discovery space, this financing is dwarfed only by Altos Lab’s $3 billion, amassed back in 2021. 14 May 2024
The world’s top 20 pharma companies spent $145 billion between them on R&D investments in 2022-23 - compared to the prior year’s $139 million - according to research from the professional services firm Deloitte. 29 April 2024
At the annual congress of the European Society of Medical Oncology (ESMO), taking place virtually, Johnson & Johnson’s pharma arm Janssen hopes to raise the bar with quality of life data for Erleada (apalutamide). 17 September 2020
US tech-based therapy firm Click Therapeutics has notched up another big pharma partner, as its joins with Germany’s Boehringer Ingelheim for the development and commercialization of a prescription-based digital therapeutic. 11 September 2020
Germany’s Bayer and USA-based Recursion Pharmaceuticals, a digital biology company industrializing drug discovery, have entered into a strategic collaboration. 9 September 2020
Pierre-Georges Roy, partner at M&A advisor Results International, provides an Expert View on why deals kept being made even as much of society shut down. 18 August 2020
Developments in artificial intelligence (AI) and machine learning (ML) are playing an increasingly influential role in the biotech space, driving the formation of new partnerships ,between the tech and healthcare industries. 3 August 2020
Artificial intelligence specialist Healx has launched a partnership with Muscular Dystrophy UK (MDUK) to find novel therapies for facioscapulohumeral muscular dystrophy (FSHD). 15 July 2020
Akili, a funded entity of London-listed biotech firm PureTech Health, today announced that it has received a Conformité Européenne (CE) Mark for EndeavorRx (AKL-T01) as a prescription-only digital therapeutic software intended for the treatment of attention and inhibitory control deficits in pediatric patients with attention deficit hyperactivity disorder (ADHD). 23 June 2020
London-listed biotech firm PureTech Health’s founded entity, Akili Interactive, has gained US Food and Drug Administration clearance for EndeavorRx (AKL-T01) as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). 16 June 2020
The Artificial Intelligence (AI) and Machine Learning industry is growing at an extraordinary rate, with healthcare professionals increasingly turning to AI to transform the patient experience and quality of care. 23 April 2020
Digital marketing in pharma is gaining increasing importance in recent times and Indian drugmaker can be termed as a pioneer in this space from the Indian market perspective, as it has successfully used a digital strategy to promote disease awareness and grow leadership position in asthma, says data and analytics company GlobalData. 4 March 2020
Researchers at the Massachusetts Institute of Technology (MIT) have claimed that they have identified a powerful new antibiotic compound using artificial intelligence (AI). 21 February 2020
finnCap, an adviser and broker to ambitious growth companies, has released a new report showing the extent to which healthcare companies can benefit from employing artificial intelligence (AI). 31 January 2020
A new report has been published by the joint Big Data Task Force of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). 20 January 2020